Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Evolent Health Q4 Earnings

Evolent Health (NYSE:EVH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:02 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
February 23, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Evolent Health (NYSE:EVH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:02 PM.

Here’s what investors need to know about the announcement.

Earnings

Evolent Health beat estimated earnings by 700.0%, reporting an EPS of $0.08 versus an estimate of $0.01.

Revenue was up $23.57 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 4.8% increase in the share price the next day.

Here’s a look at Evolent Health’s past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.03 -0.04 -0.06 -0.05
EPS Actual -0.03 -0.02 -0.01 -0.01
Revenue Estimate 225.62M 216.92M 212.79M 261.55M
Revenue Actual 222.47M 222.06M 215.07M 271.92M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs

By Shanthi Rexaline
Today, 6:02 PM
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears, and exerted negative pressure on stocks. There were very few stock-specific catalysts, barring a few preannouncements, stock offerings, and a slew of initial public offerings.

ABT